🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/04/1980 | 1,80 | 1,83 | 1,78 | 1,81 | +0,56% | 2,77% | 3.361.565 |
| 01/04/1980 | 1,79 | 1,81 | 1,78 | 1,80 | +0,37% | 2,03% | 5.855.386 |
| 31/03/1980 | 1,71 | 1,80 | 1,70 | 1,79 | +4,65% | 6,01% | 3.667.162 |
| 28/03/1980 | 1,67 | 1,72 | 1,67 | 1,71 | +2,79% | 2,98% | 3.335.155 |
| 27/03/1980 | 1,64 | 1,67 | 1,63 | 1,66 | +1,21% | 2,62% | 2.825.827 |
| 26/03/1980 | 1,67 | 1,69 | 1,64 | 1,64 | -1,39% | 2,78% | 3.704.890 |
| 25/03/1980 | 1,61 | 1,67 | 1,60 | 1,67 | +3,50% | 3,91% | 1.675.123 |
| 24/03/1980 | 1,64 | 1,64 | 1,59 | 1,61 | -1,62% | 3,24% | 2.780.554 |
| 21/03/1980 | 1,64 | 1,65 | 1,63 | 1,64 | -0,40% | 1,01% | 2.150.496 |
| 20/03/1980 | 1,65 | 1,65 | 1,63 | 1,64 | -0,21% | 1,41% | 3.731.299 |
| 19/03/1980 | 1,66 | 1,67 | 1,65 | 1,65 | -0,80% | 1,19% | 4.104.806 |
| 18/03/1980 | 1,60 | 1,67 | 1,60 | 1,66 | +3,72% | 4,34% | 3.429.475 |
| 17/03/1980 | 1,63 | 1,63 | 1,60 | 1,60 | -2,42% | 2,23% | 1.229.933 |
| 14/03/1980 | 1,66 | 1,66 | 1,63 | 1,64 | -1,00% | 1,80% | 2.048.630 |
| 13/03/1980 | 1,64 | 1,67 | 1,64 | 1,66 | +1,42% | 1,82% | 3.342.701 |
| 12/03/1980 | 1,67 | 1,67 | 1,62 | 1,63 | -2,57% | 3,37% | 5.927.069 |
| 11/03/1980 | 1,66 | 1,68 | 1,66 | 1,68 | +2,23% | 1,20% | 5.738.429 |
| 10/03/1980 | 1,60 | 1,64 | 1,59 | 1,64 | +2,48% | 3,11% | 3.968.986 |
| 07/03/1980 | 1,56 | 1,61 | 1,56 | 1,60 | +2,77% | 3,40% | 4.761.274 |
| 06/03/1980 | 1,58 | 1,58 | 1,54 | 1,56 | -2,08% | 2,51% | 5.696.928 |
| 05/03/1980 | 1,62 | 1,63 | 1,59 | 1,59 | -1,64% | 2,46% | 4.972.550 |
| 04/03/1980 | 1,63 | 1,63 | 1,60 | 1,62 | -2,01% | 1,63% | 4.489.632 |
| 03/03/1980 | 1,68 | 1,69 | 1,64 | 1,65 | -1,77% | 2,96% | 2.799.418 |
| 29/02/1980 | 1,62 | 1,68 | 1,62 | 1,68 | +4,54% | 3,47% | 4.127.443 |
| 28/02/1980 | 1,64 | 1,67 | 1,60 | 1,61 | -2,22% | 4,23% | 3.904.848 |
| 27/02/1980 | 1,70 | 1,70 | 1,64 | 1,64 | -3,32% | 3,71% | 4.806.547 |
| 26/02/1980 | 1,72 | 1,72 | 1,68 | 1,70 | -1,35% | 1,93% | 3.414.384 |
| 25/02/1980 | 1,72 | 1,72 | 1,70 | 1,72 | -0,38% | 1,16% | 2.663.597 |
| 22/02/1980 | 1,72 | 1,75 | 1,72 | 1,73 | +0,38% | 1,74% | 5.368.694 |
| 21/02/1980 | 1,78 | 1,80 | 1,71 | 1,72 | -3,34% | 5,02% | 3.418.157 |